Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD)
Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XIII Medicinal Products
Joint committee decision (JCD)
061/2009
In force in the EEA
Yes
Legal Documents
Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency
Reglugerð Evrópuþingsins og ráðsins (EB) nr. 726/2004. frá 31. mars 2004 um málsmeðferð Bandalagsins við veitingu leyfa fyrir manna- og dýralyfjum og eftirlit með þeim lyfjum og um stofnun Lyfjastofnunar Evrópu
Verordnung (EG) Nr. 726/2004 des Europäischen Parlaments und des Rates vom 31. März 2004 zur Festlegung von Gemeinschaftsverfahren für die Genehmigung und Überwachung von Human- und Tierarzneimitteln und zur Errichtung einer Europäischen Arzneimittel-Agentur
Europaparlaments- og rådsforordning (EF) nr. 726/2004 av 31. mars 2004 om fastsettelse av framgangsmåter i Fellesskapet for godkjenning og overvåking av legemidler for mennesker og veterinærpreparater og om opprettelse av et europeisk legemiddelkontor
History
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.